Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sokka

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Best Practice & Research. Clinical Rheumatology|May 19, 2001
How can the risk of long-term consequences of rheumatoid arthritis be reduced?T Pincus, T Sokka
Clinical and Experimental Rheumatology|March 3, 2004
Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 yearsT Pincus, T Sokka
Clinical and Experimental Rheumatology|December 17, 2008
Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseasesT Sokka, A Häkkinen
The Journal of Endocrinology|November 1, 1990
Ontogeny of gonadotrophin receptors and gonadotrophin-stimulated cyclic AMP production in the neonatal rat ovaryT Sokka, I Huhtaniemi
The Journal of Rheumatology|July 27, 2001
Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses?T Pincus, T Sokka
Rheumatology (Oxford, England)|December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be?T Pincus, T Sokka
Clinical and Experimental Rheumatology|December 17, 2008
Mortality in rheumatic diseases. IntroductionT Pincus, T Sokka
Clinical and Experimental Rheumatology|November 9, 2005
Quantitative joint assessment in rheumatoid arthritisT Sokka, T Pincus
Clinical and Experimental Rheumatology|February 19, 2004
A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritisT Sokka, T Pincus
Rheumatology (Oxford, England)|March 16, 2006
Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?T Pincus, T Sokka
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Best Practice & Research. Clinical Rheumatology|May 19, 2001
How can the risk of long-term consequences of rheumatoid arthritis be reduced?T Pincus, T Sokka
Clinical and Experimental Rheumatology|March 3, 2004
Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 yearsT Pincus, T Sokka
Clinical and Experimental Rheumatology|December 17, 2008
Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseasesT Sokka, A Häkkinen
The Journal of Endocrinology|November 1, 1990
Ontogeny of gonadotrophin receptors and gonadotrophin-stimulated cyclic AMP production in the neonatal rat ovaryT Sokka, I Huhtaniemi
The Journal of Rheumatology|July 27, 2001
Quantitative target values of predictors of mortality in rheumatoid arthritis as possible goals for therapeutic interventions: an alternative approach to remission or ACR20 responses?T Pincus, T Sokka
Rheumatology (Oxford, England)|December 22, 2004
How aggressive should initial therapy for rheumatoid arthritis be?T Pincus, T Sokka
Clinical and Experimental Rheumatology|December 17, 2008
Mortality in rheumatic diseases. IntroductionT Pincus, T Sokka
Clinical and Experimental Rheumatology|November 9, 2005
Quantitative joint assessment in rheumatoid arthritisT Sokka, T Pincus
Clinical and Experimental Rheumatology|February 19, 2004
A historical perspective concerning population-based and clinical studies of early arthritis and early rheumatoid arthritisT Sokka, T Pincus
Rheumatology (Oxford, England)|March 16, 2006
Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?T Pincus, T Sokka
Pageof 9